Among a subset of Blue Cross and Blue Shield Plans, outpatient specialty pharmaceutical spending* approached $1 billion in 2003.

* Based on medical and pharmacy claims data from ten Blue Cross and Blue Shield companies for 20 drug classes.
Source: Adapted from Health Affairs, from Variability and Growth in Spending for Outpatient Specialty Pharmaceuticals., Mullins, CD et al., 24, 4, 2005